Therefore, Cyclin D1 may also be employed as a molecular diagnostic biomarker in ES. Interestingly, another ES variant, the BCOR–CCNB3 fusion-positive sarcoma, has also been shown to up-regulate CCND1 (Kao et al. 2018). This evidence concerns the gene CCNB3 and sarcoma.